Invention Grant
- Patent Title: Alkynyl nucleoside analogs as inhibitors of human rhinovirus
-
Application No.: US15465485Application Date: 2017-03-21
-
Publication No.: US09988416B2Publication Date: 2018-06-05
- Inventor: Martijn Fenaux , Oliver Saunders , Fumiaki Yokokawa , Weidong Zhong
- Applicant: NOVARTIS AG
- Applicant Address: CH Basel
- Assignee: Novartis AG
- Current Assignee: Novartis AG
- Current Assignee Address: CH Basel
- Agent Mark H. Hopkins
- Priority: SG10201602360R 20160324
- Main IPC: C07H19/14
- IPC: C07H19/14 ; A61K31/7064 ; C07H19/04 ; C07D487/04
Abstract:
The present invention provides a compound of Formula (I) or a salt thereof; and therapeutic uses of these compounds. The invention further provides pharmaceutical compositions comprising these compounds, and compositions comprising these compounds with a therapeutic co-agent, and methods of using the compounds and compositions for treatment of viral infections, especially HRV.
Public/Granted literature
- US20170275329A1 ALKYNYL NUCLEOSIDE ANALOGS AS INHIBITORS OF HUMAN RHINOVIRUS Public/Granted day:2017-09-28
Information query
IPC分类:
